
| • |
Completed successful sampling of 5G chipset and modules to all lead customers, who are actively progressing through their evaluation process
and have subsequently provided increasingly positive feedback.
|
| • |
Received initial 5G product revenue during the third quarter of 2025 as part of the sampling with lead customers.
|
| • |
First 5G network operator has publicly signalled full-service activation before year-end 2025, marking the initial deployment in what is
expected to be a multi-operator transition from chipset sampling to customer activation using GCT’s 5G platform.
|
| • |
Including sample shipments to-date, initial 5G chipset orders already exceed 2,500 units, underscoring strong early demand in the first stage
of anticipated acceleration as network operator deployments scale.
|
| • |
Secured $10.7 million debt financing in September 2025 with the net proceeds allocated to accelerate final production readiness and
preparations for mass production and volume shipments of the 5G chipsets as well as other working capital requirements.
|
| • |
Net revenues were $0.4 million, an 84.0% decrease from $2.6 million.
|
| • |
Gross margin for the three months ended September 30, 2024, was 62%. Our current gross margin for the three months ended September 30, 2025, is negative and not meaningful, as we continue to
experience lower product revenue, which is currently not sufficient to fully absorb production overhead costs. This makes our current gross margins less indicative of the underlying profitability of our product and services. We expect
operational efficiencies to improve as revenues increase after 5G product sales start contributing more significantly to our overall revenue commencing in Q1 2026.
|
| • |
Total operating expenses were $8.2 million, a 9.0% increase from $7.5 million.
|
| • |
Investor relations website: investors.gctsemi.com
|
| • |
Investor relations contact: Gateway Group, Ralf Esper, GCT@gateway-grp.com
|
| • |
Media contact: media@gctsemi.com
|
|
September 30, 2025
|
December 31, 2024
|
|||||||
|
Assets
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
8,343
|
$
|
1,435
|
||||
|
Accounts receivable, net
|
3,686
|
5,740
|
||||||
|
Inventory
|
1,905
|
2,977
|
||||||
|
Contract assets
|
5,631
|
5,107
|
||||||
|
Prepaid expenses and other current assets
|
2,302
|
2,332
|
||||||
|
Total current assets
|
21,867
|
17,591
|
||||||
|
Property and equipment, net
|
1,582
|
869
|
||||||
|
Operating lease right-of-use assets
|
412
|
849
|
||||||
|
Intangibles, net
|
10
|
65
|
||||||
|
Other assets
|
404
|
523
|
||||||
|
Total assets
|
$
|
24,275
|
$
|
19,897
|
||||
|
Liabilities and Stockholders’ Deficit
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$
|
1,053
|
$
|
1,031
|
||||
|
Contract liabilities
|
11
|
48
|
||||||
|
Accrued and other current liabilities
|
20,970
|
21,205
|
||||||
|
Common stock forward liability
|
4
|
315
|
||||||
|
Borrowings
|
59,413
|
37,626
|
||||||
|
Convertible promissory notes, current
|
5,287
|
—
|
||||||
|
Operating lease liabilities, current
|
372
|
697
|
||||||
|
Total current liabilities
|
87,110
|
60,922
|
||||||
|
Convertible promissory notes, net of current
|
—
|
4,947
|
||||||
|
Net defined benefit liabilities
|
7,913
|
7,055
|
||||||
|
Long-term operating lease liabilities
|
63
|
177
|
||||||
|
Income taxes payable
|
2,330
|
2,076
|
||||||
|
Warrant liabilities
|
6,923
|
3,750
|
||||||
|
Other liabilities
|
85
|
285
|
||||||
|
Total liabilities
|
104,424
|
79,212
|
||||||
|
Stockholders’ deficit:
|
||||||||
|
Preferred stock
|
—
|
—
|
||||||
|
Common stock
|
6
|
5
|
||||||
|
Additional paid-in capital
|
515,603
|
501,195
|
||||||
|
Accumulated other comprehensive income
|
630
|
1,518
|
||||||
|
Accumulated deficit
|
(596,388
|
)
|
(562,033
|
)
|
||||
|
Total stockholders’ deficit
|
(80,149
|
)
|
(59,315
|
)
|
||||
|
Total liabilities and stockholders’ deficit
|
$
|
24,275
|
$
|
19,897
|
||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Net revenues:
|
||||||||||||||||
|
Product
|
$
|
148
|
$
|
1,715
|
$
|
647
|
$
|
4,111
|
||||||||
|
Service
|
282
|
895
|
1,461
|
3,232
|
||||||||||||
|
Total net revenues
|
430
|
2,610
|
2,108
|
7,343
|
||||||||||||
|
Cost of net revenues:
|
||||||||||||||||
|
Product
|
1,419
|
710
|
2,208
|
1,522
|
||||||||||||
|
Service
|
61
|
274
|
484
|
1,321
|
||||||||||||
|
Total cost of net revenues
|
1,480
|
984
|
2,692
|
2,843
|
||||||||||||
|
Gross profit (loss)
|
(1,050
|
)
|
1,626
|
(584
|
)
|
4,500
|
||||||||||
|
Operating expenses:
|
||||||||||||||||
|
Research and development
|
3,258
|
4,210
|
10,868
|
13,895
|
||||||||||||
|
Sales and marketing
|
1,048
|
949
|
3,187
|
2,921
|
||||||||||||
|
General and administrative
|
3,898
|
2,379
|
9,947
|
8,075
|
||||||||||||
|
Gain on extinguishment of liability
|
—
|
—
|
—
|
(14,636
|
)
|
|||||||||||
|
Total operating expenses
|
8,204
|
7,538
|
24,002
|
10,255
|
||||||||||||
|
Loss from operations
|
(9,254
|
)
|
(5,912
|
)
|
(24,586
|
)
|
(5,755
|
)
|
||||||||
|
Interest expense
|
(1,783
|
)
|
(667
|
)
|
(4,385
|
)
|
(3,509
|
)
|
||||||||
|
Gain (loss) on foreign currency transactions, net
|
1,320
|
(1,044
|
)
|
(1,876
|
)
|
1,244
|
||||||||||
|
Change in fair value of common stock forward liability
|
16
|
—
|
311
|
(586
|
)
|
|||||||||||
|
Change in fair value of common stock warrant liabilities
|
(3,812
|
)
|
759
|
(3,173
|
)
|
2,761
|
||||||||||
|
Change in fair value of convertible promissory notes
|
(164
|
)
|
(165
|
)
|
(340
|
)
|
(1,354
|
)
|
||||||||
|
Other income (expenses), net
|
6
|
(31
|
)
|
16
|
(21
|
)
|
||||||||||
|
Loss before provision for income taxes
|
(13,671
|
)
|
(7,060
|
)
|
(34,033
|
)
|
(7,220
|
)
|
||||||||
|
Provision for income taxes
|
178
|
61
|
322
|
187
|
||||||||||||
|
Net loss
|
$
|
(13,849
|
)
|
$
|
(7,121
|
)
|
$
|
(34,355
|
)
|
$
|
(7,407
|
)
|
||||
|
Net loss per common share:
|
||||||||||||||||
|
Basic and diluted
|
$
|
(0.25
|
)
|
$
|
(0.16
|
)
|
$
|
(0.67
|
)
|
$
|
(0.19
|
)
|
||||
|
Weighted average common shares outstanding:
|
||||||||||||||||
|
Basic and diluted
|
55,462
|
45,645
|
51,619
|
38,418
|
||||||||||||